A detailed history of Russell Investments Group, Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 298 shares of AXGN stock, worth $4,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
298
Previous 13,798 97.84%
Holding current value
$4,964
Previous $99,000 95.96%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.52 - $14.69 $101,520 - $198,315
-13,500 Reduced 97.84%
298 $4,000
Q2 2024

Aug 08, 2024

BUY
$5.67 - $8.06 $76,545 - $108,810
13,500 Added 4530.2%
13,798 $99,000
Q1 2024

May 08, 2024

SELL
$6.63 - $10.69 $80,229 - $129,359
-12,101 Reduced 97.6%
298 $2,000
Q4 2023

Feb 05, 2024

SELL
$3.61 - $7.76 $13,602 - $29,239
-3,768 Reduced 23.31%
12,399 $84,000
Q3 2023

Nov 13, 2023

SELL
$4.68 - $9.26 $978 - $1,935
-209 Reduced 1.28%
16,167 $80,000
Q2 2023

Aug 10, 2023

BUY
$8.5 - $10.38 $2,261 - $2,761
266 Added 1.65%
16,376 $149,000
Q1 2023

May 09, 2023

BUY
$7.53 - $10.95 $117,324 - $170,611
15,581 Added 2945.37%
16,110 $152,000
Q3 2022

Nov 04, 2022

SELL
$8.14 - $12.25 $214,790 - $323,240
-26,387 Reduced 98.03%
529 $6,000
Q2 2022

Jul 29, 2022

SELL
$6.99 - $10.0 $21,641 - $30,960
-3,096 Reduced 10.32%
26,916 $219,000
Q1 2022

May 05, 2022

BUY
$7.26 - $10.7 $76,338 - $112,510
10,515 Added 53.93%
30,012 $237,000
Q4 2021

Jan 21, 2022

BUY
$8.8 - $16.0 $171,573 - $311,952
19,497 New
19,497 $182,000
Q2 2021

Aug 04, 2021

SELL
$17.8 - $23.5 $1.79 Million - $2.37 Million
-100,766 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$17.18 - $22.6 $733,293 - $964,635
42,683 Added 73.49%
100,766 $2.04 Million
Q4 2020

Feb 08, 2021

BUY
$11.5 - $17.96 $667,954 - $1.04 Million
58,083 New
58,083 $1.04 Million
Q3 2020

Nov 09, 2020

SELL
$10.62 - $13.12 $164,386 - $203,084
-15,479 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$7.35 - $10.81 $55,610 - $81,788
-7,566 Reduced 32.83%
15,479 $143,000
Q4 2019

Jan 29, 2020

BUY
$11.18 - $18.6 $8,597 - $14,303
769 Added 3.45%
23,045 $412,000
Q3 2019

Nov 01, 2019

BUY
$12.09 - $20.46 $129,943 - $219,904
10,748 Added 93.23%
22,276 $278,000
Q2 2019

Aug 09, 2019

SELL
$18.5 - $25.47 $588,263 - $809,895
-31,798 Reduced 73.39%
11,528 $228,000
Q1 2019

May 13, 2019

BUY
$14.62 - $22.13 $97,120 - $147,009
6,643 Added 18.11%
43,326 $912,000
Q4 2018

Feb 11, 2019

SELL
$17.09 - $38.25 $216,837 - $485,316
-12,688 Reduced 25.7%
36,683 $747,000
Q3 2018

Oct 26, 2018

SELL
$34.05 - $55.9 $2.05 Million - $3.37 Million
-60,296 Reduced 54.98%
49,371 $1.82 Million
Q2 2018

Aug 08, 2018

SELL
$36.15 - $52.5 $2.38 Million - $3.45 Million
-65,756 Reduced 37.48%
109,667 $5.52 Million
Q1 2018

May 11, 2018

SELL
$24.4 - $40.25 $4.81 Million - $7.94 Million
-197,203 Reduced 52.92%
175,423 $6.4 Million
Q4 2017

Feb 06, 2018

SELL
$18.5 - $28.6 $3.88 Million - $6 Million
-209,899 Reduced 36.03%
372,626 $10.7 Million
Q3 2017

Nov 07, 2017

BUY
$14.65 - $19.35 $8.53 Million - $11.3 Million
582,525
582,525 $11.3 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $704M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.